Paradoxical prognostic phenomenon of plasma T-cell-derived circulating DNA level in advanced non-small cell lung cancer

ConclusionT-cirDNA could be a novel biomarker representing adaptive immune resistance in NSCLC patients. Further exploration as a predictive biomarker for EGFR inhibitors in setting ofEGFR mutation might be warranted.
Source: Clinical and Translational Oncology - Category: Cancer & Oncology Source Type: research